CASI Pharmaceuticals, Inc.
(NASDAQ : CASI)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -0.48%333.250.0%$4524.80m
NVAXNovavax, Inc. -1.01%164.5679.4%$740.26m
BNTXBioNTech SE 1.05%263.830.0%$712.20m
AMGNAmgen, Inc. 1.31%205.781.4%$545.27m
REGNRegeneron Pharmaceuticals, Inc. 1.91%553.842.7%$427.56m
SNSSSunesis Pharmaceuticals, Inc. -2.48%6.110.7%$427.11m
GILDGilead Sciences, Inc. 1.54%66.921.0%$414.14m
CCXIChemoCentryx, Inc. 5.27%34.142.9%$405.51m
ILMNIllumina, Inc. 0.04%410.713.3%$374.83m
XLRNAcceleron Pharma, Inc. 0.25%173.445.3%$363.37m
VRTXVertex Pharmaceuticals, Inc. 1.61%183.711.9%$262.42m
BIIBBiogen, Inc. -0.04%269.611.7%$233.56m
OCGNOcugen, Inc. 2.60%8.480.0%$183.30m
XENEXenon Pharmaceuticals, Inc. -0.81%30.470.4%$170.35m
CRSPCRISPR Therapeutics AG 4.33%100.380.6%$160.89m

Company Profile

CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs. The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong, and Macau. Its products include Zevalin, Evomela, and Marqibo. The company was founded in 1991 and is headquartered in Rockville, MD.